At a glance
- Originator Nonindustrial source
- Class Alkaloids; Antineoplastics; Small molecules
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 17 Aug 2001 Discontinued-Preclinical for Cancer in Israel (Unknown route)
- 17 Aug 2001 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 09 Jul 1998 Profile reviewed